Terms: = Kidney tumors AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Diagnosis
163 results:
1. Histomorphometric and Immunohistochemical diagnosis of Renal Cell Carcinoma: Review Article.
Deka D; Chakravarty M
Mymensingh Med J; 2024 Apr; 33(2):636-642. PubMed ID: 38557550
[TBL] [Abstract] [Full Text] [Related]
2. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Recurrent Gastric GIST Who Survived for Long after Laparoscopic Resection and Imatinib Therapy].
Yabe N; Takenoya T; Oto I; Harada Y; Kondo A; Ogiso M; Maeda H; Asada Y; Sako H; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1718-1720. PubMed ID: 38303184
[TBL] [Abstract] [Full Text] [Related]
4. [Morphological and molecular portrait hybrid renal tumors].
Osmanov YI; Kogan EA; Gadzhieva ZK; Prochenko DD
Urologiia; 2023 Sep; (4):113-116. PubMed ID: 37850290
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
[TBL] [Abstract] [Full Text] [Related]
6. Oncocytoma-Like Angiomyolipoma of the kidney: A Closer Look into the Clinicopathologic, Immunohistochemical, and Molecular Characteristics of a Rare Entity with Review of the Literature.
Doytcheva K; Storozuk T; Tjota M; Antic T
Int J Surg Pathol; 2024 May; 32(3):625-631. PubMed ID: 37487196
[No Abstract] [Full Text] [Related]
7. GPD1L inhibits renal cell carcinoma progression by regulating PINK1/Parkin-mediated mitophagy.
Liu T; Zhu H; Ge M; Pan Z; Zeng Y; Leng Y; Yang K; Cheng F
J Cell Mol Med; 2023 Aug; 27(16):2328-2339. PubMed ID: 37382962
[TBL] [Abstract] [Full Text] [Related]
8. Concordance of MTOR Pathway Mutations and the diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).
Siegmund SE; Al-Obaidy KI; Tsai HK; Idrees MT; Akgul M; Acosta AM; Hirsch MS
Int J Surg Pathol; 2024 Apr; 32(2):316-330. PubMed ID: 37357748
[TBL] [Abstract] [Full Text] [Related]
9. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
10. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
[No Abstract] [Full Text] [Related]
11. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
12. A case of TFE3 translocation renal cell carcinoma with rare morphological features and literature review.
Xia T; Long H; Liao D; Wang W; Xiao X
Indian J Pathol Microbiol; 2023; 66(1):135-140. PubMed ID: 36656224
[TBL] [Abstract] [Full Text] [Related]
13. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.
Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
[TBL] [Abstract] [Full Text] [Related]
14. Algorithm-Based Approach to the Histological Routine diagnosis of Renal Oncocytic tumors in Core Biopsy Specimens.
Manini C; Imaz I; de Larrinoa AF; López JI
Curr Urol Rep; 2022 Nov; 23(11):327-333. PubMed ID: 36169870
[TBL] [Abstract] [Full Text] [Related]
15. Gastrointestinal tumors in transplantation: Two case reports and review of literature.
Stammler R; Anglicheau D; Landi B; Meatchi T; Ragot E; Thervet E; Lazareth H
World J Gastroenterol; 2022 Sep; 28(34):5076-5085. PubMed ID: 36160649
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract] [Full Text] [Related]
17. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
[TBL] [Abstract] [Full Text] [Related]
18. LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.
Du J; Xiao J; Zhuo Y; Nie M; Yang J; Luo X; Gu H
Anticancer Drugs; 2022 Sep; 33(8):720-730. PubMed ID: 35946509
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma.
Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y
Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922
[TBL] [Abstract] [Full Text] [Related]
20. [Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].
Zhang HZ; Xia QY; Yin XG; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):437-443. PubMed ID: 35511640
[No Abstract] [Full Text] [Related]
[Next]